Tuesday, October 2, 2012

Health - Google News: J&J Experimental Diabetes Drug Helps High-Risk Patients - Businessweek

Health - Google News
Google News
J&J Experimental Diabetes Drug Helps High-Risk Patients - Businessweek
Oct 2nd 2012, 10:19


J&J Experimental Diabetes Drug Helps High-Risk Patients
Businessweek
By Michelle Fay Cortez on October 02, 2012 Johnson & Johnson (JNJ)'s experimental diabetes drug helped the most vulnerable patients in two studies, including older people who struggle to get their blood sugar under control and those at high risk of ...
J&J diabetes drug effective in high risk patients - studyYahoo! News (blog)
First Results from Phase 3 CANVAS Trial Show Canagliflozin as Add-on Therapy ...PR Newswire (press release)

all 16 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

0 comments:

Post a Comment

Twitter Delicious Facebook Digg Stumbleupon Favorites More